Target intelligence / Profile preview

RNA, U6atac small nuclear (RNU6ATAC)

Target
RNU6ATAC
Molecular classification
Other (non-coding RNA; minor spliceosome small nuclear RNA)
01

Overview

RNA, U6atac small nuclear (RNU6ATAC) is a small non-coding nuclear RNA (snRNA) that is a critical catalytic component of the minor (U12-dependent) spliceosome, a specialized cellular machine responsible for the splicing of a rare subclass of introns (minor or U12-type introns) from precursor messenger RNAs (pre-mRNAs)[1][2][3][4]. The minor spliceosome consists of distinct snRNAs (U11, U12, U4atac, U6atac, U5), and U6atac is essential for the catalytic core of this complex[1][2][3]. U6atac is highly unstable compared to other snRNAs and serves as a rate-limiting factor in the splicing of minor introns, which affects expression of hundreds of genes involved in diverse and critical cellular pathways[1]. Its abundance can be regulated by cellular stress pathways such as p38MAPK, thus influencing gene expression post-transcriptionally[1]. Although dysregulation of minor intron splicing, via changes in U6atac, impacts pathways important in diseases (e.g., tumor suppressor expression, cytokine regulation), RNU6ATAC is not itself a classic therapeutic target such as a receptor, enzyme, or transporter, and no drugs are known to directly interact with it[1][4].

Other names
RNU6ATAC1RNA, U6atac small nuclear 1U6ATACRNA, U6atac small nuclear (U12-dependent splicing)
02

Biological functions

Minor intron splicingPre-mRNA processingRegulation of gene expression (post-transcriptional)
03

Disease associations

Other (not directly implicated as a causal factor but affects expression of disease-related genes through minor intron splicing)

Beyond the preview

Go deeper on RNA, U6atac small nuclear (RNU6ATAC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6atac small nuclear (RNU6ATAC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call